Evidence map›Paper›PMID 36075840›Full record

ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2023

Corrigendum to "Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation": [Annals of Oncology 28 (2017):2503-2510].

H Takamatsu, N Takezako, J Zheng, M Moorhead, V E H Carlton, K A Kong, R Murata, S Ito, T Miyamoto, K Yokoyama and 10 more

Abstract readPublished Erratum
In one paragraph

Article in Annals of oncology : official journal of the European Society for Medical Oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

H TakamatsuHematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. Electronic address: takamaz@staff.kanazawa-u.ac.jp.
N TakezakoDepartment of Hematology, National Hospital Organization Disaster Medical Center of Japan, Tachikawa, Japan.
J ZhengAdaptive Biotechnologies Corp., South San Francisco, USA.
M MoorheadAdaptive Biotechnologies Corp., South San Francisco, USA.
V E H CarltonAdaptive Biotechnologies Corp., South San Francisco, USA.
K A KongAdaptive Biotechnologies Corp., South San Francisco, USA.
R MurataDivision of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa, Japan.
S ItoDepartment of Medical Oncology, Iwate Medical University School of Medicine, Morioka, Japan.
T MiyamotoMedicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
K YokoyamaDepartment of Hematology/Oncology, Tokai University Hachioji Hospital, Hachioji, Japan.
K MatsueDivision of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa, Japan.
T SatoDepartment of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan.
T KurokawaDepartment of Hematology, Toyama Red Cross Hospital, Toyama, Japan.
H YagiDepartment of Hematology, Kinki University School of Medicine Nara Hospital, Ikoma, Nara, Japan.
Y TerasakiDivision of Internal Medicine, Toyama City Hospital, Toyama, Japan.
K OhataHematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
M MatsumotoDepartment of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa, Japan.
T YoshidaDepartment of Hematology, Shizuoka City Shimizu Hospital, Shizuoka, Japan.
M FahamAdaptive Biotechnologies Corp., South San Francisco, USA.
S NakaoHematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID36075840
PMCPMC12247114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.